AMGEN
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Recent news mentioning AMGEN
- — How Is Amgen’s Stock Performance Compared to Other General Drug Manufacturers
- — AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
- — Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- — Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?
- — Amgen Stock And The Price Of A Promise
- — Amgen gains after strong quarterly results and continued product momentum
- — Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter Smash
- — Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513
- — Amgen Q2 Earnings Call Highlights
- — Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment
- — Amgen second-quarter sales rise 9%, profit tops Street view
- — PRIVACY ALERT: Amgen Under Investigation for Data Breach of Records